Alternate Names: CH50; Complement assay; CH100
How Performed: Adult or child:
Blood is drawn from a vein (venipuncture), usually from the inside of the elbow or the back of the hand. The puncture site is cleaned with antiseptic, and a tourniquet (an elastic band) or blood pressure cuff is placed around the upper arm to apply pressure and restrict blood flow through the vein. This causes veins below the tourniquet to distend (fill with blood). A needle is inserted into the vein, and the blood is collected in an air-tight vial or a syringe. During the procedure, the tourniquet is removed to restore circulation. Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding.
Infant or young child:
The area is cleansed with antiseptic and punctured with a sharp needle or a lancet. The blood may be collected in a pipette (small glass tube), on a slide, onto a test strip, or into a small container. Cotton or a bandage may be applied to the puncture site if there is any continued bleeding.
The blood is tested in a laboratory.
How To Prepare: Adults:
There is no special preparation.
Infants and children:
The physical and psychological preparation you can provide for this or any test or procedure depends on your child’s age, interests, previous experience, and level of trust. For specific information regarding how you can prepare your child, see the following topics as they correspond to your child’s age:
How It Feels: When the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing.
Risks:
- excessive bleeding
- fainting or feeling lightheaded
- hematoma (blood accumulating under the skin)
- infection (a slight risk any time the skin is broken)
- multiple punctures to locate veins
Why Performed: Complement activity (CH50, CH100, terminal complement component, or individual complement proteins) is measured to determine if complement is involved in the pathogenesis of a number of diseases. Complement activity is also measured to monitor severity of a disease or determine efficacy of treatment. For example, patients with active lupus erythematosus may have depressed levels of C3 and C4, and these component levels may be followed as a rough index of disease activity.
Complement activity may vary in different body compartments. For example, complement activity in the blood of patients with rheumatoid arthritis may be normal or increased, but in joint fluid it is severely depressed.
Patients with gram negative septicemia and shock are often depleted of C3 and components of the alternative pathway. C3 is often also depressed in fungal infections and some parasitic infections such as malaria.
Normal Values:
- Total hemolytic complement level: 41 to 90 hemolytic units
- C1 esterase inhibitor level: 16 to 33 mg/dl (160 to 330 mg/L)
- C3 levels:
- males: 88 to 252 mg/dl (880 to 2520 mg/L)
- females: 88 to 206 mg/dl (880 to 2060 mg/L)
- C4 levels:
- males: 12 to 72 mg/dl (120 to 720 mg/L)
- females: 13 to 75 mg/dl (130 to 750 mg/L)
Note: mg/dl = milligrams per deciliter.
(This test may also be reported as mg/L = milligrams per liter.)
Abnormal Results: Increased complement activity may be seen in:
Decreased complement activity may be seen in:
Cost:
Special Considerations: Serum complement comprises a group of proteins that facilitate immunological and inflammatory responses. The "complement cascade" involves a series of enzymatic reactions that take place in the blood. There are 9 major components labeled C1 through C9. The cascade can be initiated by various means, especially antigen-antibody complexes. The end-product of the cascade is the "membrane attack unit" (also called terminal complement component), which creates holes in the membranes of attacking microorganisms, thereby causing lysis and death of the cells. CH50 or CH100 are 50% or 100% of ’whole’ complement activity. There are also a number of side products of the complement cascade that attract white blood cells and increase the efficiency to engulf bacteria by phagocytic white blood cells.
When many microorganisms are exposed to fresh serum, complement is activated by an "alternative pathway" that does not require the presence of specific antibodies to the microorganism. These organisms are able to bind C3 directly. Bound C3, or some modified form of C3, is able to associate with factor D, factor B, and properdin to form a stable unit capable of continuing the complement cascade.
Under normal circumstances, a complement test is not performed. Other tests that are more specific to a particular disease are considered first.
Veins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
